Market Samachar
Home  ›  GLOBAL
Language Englishతెలుగుहिन्दीதமிழ்मराठीবাংলাಕನ್ನಡ
THE WALL STREET JOURNAL · GLOBAL ·

AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion - WSJ

No preview available from this publisher — open the full story below.

▸ MARKET SAMACHAR ANALYSIS
Our editorial commentary, not the publisher's article body.

AbbVie is set to acquire immunology drugmaker Apogee for a substantial $10.9 billion, as reported by WSJ. This major acquisition marks a significant strategic move within the pharmaceutical sector, expanding AbbVie's portfolio and reinforcing its position in specialized…

▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on The Wall Street Journal ↗

Market Samachar is a news aggregator. This article was originally published by The Wall Street Journal. Tap the button above to read the full story on their site.

🔥 Hot Now
Top stories across markets in the last hour

More from Market Samachar